Association of Health-Related Quality of Life and Relapse in the Previous Year among Multiple Sclerosis Patients
Halper J, Jeffery D, Kirzinger S, Preblick R, Bi YJ, and Gemmen E.
Poster published at ISPOR EU 2009. Analysis examining the association of HRQoL and relapses that occurred in the previous year among MS patients, using data from the Real-World Betaseron® Outcomes Study (ROBUST); ROBUST is a 12-month, US, prospective, observational, open-label, single-arm, multi-center outcomes study of interferon beta-1b given every other day for MS.
